Product news

Johnson & Johnson's anemia drug Procrit has been linked to death in some patients, according to a new study. In the study, which was designed and initiated by a German scientist, more patients treated with Eprex (Procrit's name outside the US) died than in the comparison group receiving a placebo.
You must be a registered member of MMM to post a comment.